# | ||||
---|---|---|---|---|
1 | KHON2BTREAT Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market | 2018 | 3˙337˙525.00 | 2˙336˙267.00 |
The Institution KHONDRION BV has been involved also in the following Horizon 2020 projects.